Chandler, ARIZONA5 Active Studies

Liver Disease Clinical Trials in Chandler, ARIZONA

Find 5 actively recruiting liver disease clinical trials in Chandler, ARIZONA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
2,715
Enrolling

Recruiting Liver Disease Studies in Chandler

RecruitingChandler, ARIZONANCT06528314

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH....

1,150 participants
Akero Therapeutics, Inc
View Study Details
RecruitingChandler, ARIZONANCT06318169

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

1,050 participants
89bio, Inc.
View Study Details
RecruitingChandler, ARIZONANCT06613698

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease....

393 participants
GlaxoSmithKline
View Study Details
RecruitingChandler, ARIZONANCT06465186

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic s...

80 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingChandler, ARIZONANCT06920043

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis...

42 participants
Boston Pharmaceuticals
View Study Details

About Liver Disease Clinical Trials in Chandler

Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.

There are currently 5 liver disease clinical trials recruiting participants in Chandler, ARIZONA. These studies are seeking a combined 2,715 participants. Research is being sponsored by Akero Therapeutics, Inc, 89bio, Inc., GlaxoSmithKline and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Disease Clinical Trials in Chandler — FAQ

Are there liver disease clinical trials in Chandler?

Yes, there are 5 liver disease clinical trials currently recruiting in Chandler, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chandler?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you about next steps.

Are clinical trials in Chandler free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chandler studies also compensate for your time and travel.

What liver disease treatments are being tested?

The 5 active trials in Chandler are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.

Data updated March 2, 2026 from ClinicalTrials.gov